CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sangeetha Reddy
University of Texas Southwestern Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
Recruiting - Johns Hopkins University
Baltimore, Maryland, United States
Recruiting - University of North Carolina
Chapel Hill, North Carolina, United States
Yara G Abdou, MDRecruiting - Sarah Cannon Research Institute
Nashville, Tennessee, United States
Withdrawn - Texas Oncology, P.A.
Dallas, Texas, United States
Active, not recruiting - Ut Southwestern Medical Center
Dallas, Texas, United States
Recruiting - the University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Apr 2022
- Primary completion
- 20 Apr 2028
- Completion
- 20 Apr 2029
- Last update posted
- 17 Jun 2026
- Registered enrollment
- 30
- Registry id
- NCT05029999
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.